| Nov 19, 2025 |
Nov 21, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
95.0
|
+1,500,000
|
2.65%
|
✗
|
$41.1M |
| Apr 8, 2025 |
Apr 10, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
70.0
|
+187,227
|
0.28%
|
✗
|
$2.9M |
| Apr 3, 2025 |
Apr 7, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
90.0
|
+845,220
|
1.08%
|
✗
|
$13.6M |
| Mar 31, 2025 |
Apr 2, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
62.5
|
+53,969
|
0.14%
|
✗
|
$941.3K |
| Mar 26, 2025 |
Mar 28, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
70.0
|
+113,384
|
0.23%
|
✗
|
$2M |
| Mar 21, 2025 |
Mar 25, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
70.0
|
+136,696
|
0.37%
|
✗
|
$2.4M |
| Mar 18, 2025 |
Mar 20, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
70.0
|
+201,844
|
0.42%
|
✗
|
$3.6M |
| Mar 4, 2025 |
Mar 6, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
62.5
|
+27,953
|
0.08%
|
✗
|
$481.8K |
| Feb 27, 2025 |
Mar 3, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
80.0
|
+663,761
|
0.81%
|
✗
|
$11.3M |
| Feb 12, 2025 |
Feb 14, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
78.8
|
+411,430
|
0.62%
|
✗
|
$6.3M |
| Feb 6, 2025 |
Feb 10, 2025 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
100.0
|
+5,165,695
|
21.03%
|
✗
|
$10.6M |
| Jan 27, 2025 |
Jan 28, 2025 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
96.3
|
+7,894,737
|
8.65%
|
✗
|
$6M |
| Jan 14, 2025 |
Jan 16, 2025 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
62.5
|
+29,376
|
0.09%
|
✗
|
$630.8K |
| Dec 16, 2024 |
Dec 18, 2024 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
65.0
|
+80,200
|
0.15%
|
✗
|
$1.9M |
| Oct 2, 2024 |
Oct 4, 2024 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
100.0
|
+1,315,339
|
11.77%
|
✗
|
$3.9M |
| May 9, 2024 |
May 13, 2024 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
47.5
|
+1
|
0.00%
|
✗
|
$42.6 |
| Apr 11, 2024 |
Apr 15, 2024 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
100.0
|
+2,420,000
|
32.54%
|
✗
|
$7.1M |
| Feb 6, 2024 |
Feb 8, 2024 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
96.3
|
+6,730,770
|
8.79%
|
✗
|
$7M |
| Jan 8, 2024 |
Jan 10, 2024 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
52.5
|
+4,042
|
0.02%
|
✗
|
$109.6K |
| Jan 3, 2024 |
Jan 5, 2024 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
71.3
|
+226,553
|
0.43%
|
✗
|
$6.5M |
| Nov 28, 2023 |
Nov 30, 2023 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
80.0
|
+434,991
|
0.70%
|
✗
|
$13.7M |
| Nov 10, 2023 |
Nov 14, 2023 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
65.0
|
+34,827
|
0.12%
|
✗
|
$1.1M |
| Nov 7, 2023 |
Nov 9, 2023 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
78.8
|
+289,140
|
0.58%
|
✗
|
$9.7M |
| Nov 2, 2023 |
Nov 6, 2023 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
80.0
|
+309,154
|
0.64%
|
✗
|
$10.8M |
| Oct 4, 2023 |
Oct 6, 2023 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
78.8
|
+205,296
|
0.55%
|
✗
|
$7.8M |
| Sep 19, 2023 |
Sep 21, 2023 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
80.0
|
+291,383
|
0.80%
|
✗
|
$11.7M |
| Sep 5, 2023 |
Sep 7, 2023 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
78.8
|
+189,962
|
0.54%
|
✗
|
$7.9M |
| Apr 3, 2023 |
Apr 5, 2023 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
100.0
|
+26,827,638
|
36.48%
|
✗
|
$8.1M |
| Dec 27, 2022 |
Dec 29, 2022 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
78.8
|
+191,075
|
0.55%
|
✗
|
$9.1M |
| Apr 14, 2022 |
Apr 15, 2022 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
100.0
|
+6,003,752
|
14.75%
|
✗
|
$8M |
| Mar 23, 2022 |
Mar 25, 2022 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
77.5
|
+930,106
|
0.68%
|
✗
|
$1.3M |
| Jun 24, 2021 |
Jun 28, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
25.0
|
-228,443
|
-0.65%
|
✗
|
$35.7M |
| Jun 16, 2021 |
Jun 21, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
32.5
|
-107,675
|
-0.30%
|
✗
|
$16.2M |
| Jun 11, 2021 |
Jun 15, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
41.3
|
-59,550
|
-0.16%
|
✗
|
$8.8M |
| May 27, 2021 |
Jun 1, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
25.0
|
-266,278
|
-0.73%
|
✗
|
$39.1M |
| Apr 22, 2021 |
Apr 26, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
32.5
|
-117,906
|
-0.31%
|
✗
|
$15.8M |
| Feb 10, 2021 |
Feb 12, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
42.5
|
-37,451
|
-0.10%
|
✗
|
$4.7M |
| Feb 5, 2021 |
Feb 9, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
25.0
|
-257,619
|
-0.66%
|
✗
|
$31.3M |
| Feb 5, 2021 |
Feb 9, 2021 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
87.5
|
+600,000
|
1.82%
|
✗
|
$2.7M |
| Feb 2, 2021 |
Feb 4, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
41.3
|
-60,861
|
-0.15%
|
✗
|
$6.8M |
| Jan 26, 2021 |
Jan 28, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
15.0
|
-789,883
|
-1.92%
|
✗
|
$82.1M |
| Jan 20, 2021 |
Jan 22, 2021 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
92.5
|
+1,460,280
|
4.73%
|
✗
|
$5M |
| Jan 12, 2021 |
Jan 12, 2021 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
33.8
|
-60,000
|
-0.28%
|
✗
|
$5.4M |
| Apr 24, 2020 |
Apr 28, 2020 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
92.5
|
+1,050,000
|
3.70%
|
✗
|
$2.4M |
| Jan 2, 2020 |
Jan 6, 2020 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
92.5
|
+1,391,466
|
3.57%
|
✗
|
$3M |
| Nov 13, 2019 |
Nov 15, 2019 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
95.0
|
+1,176,471
|
5.03%
|
✗
|
$2M |
| Sep 11, 2019 |
Sep 13, 2019 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
95.0
|
+2,000,000
|
9.90%
|
✗
|
$3.3M |
| Aug 13, 2019 |
Aug 15, 2019 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+24,553
|
0.02%
|
✗
|
$24K |
| Jul 2, 2019 |
Jul 2, 2019 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
95.0
|
+1,000,000
|
5.82%
|
✗
|
$2M |
| May 3, 2019 |
May 3, 2019 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
70.0
|
+100,000
|
0.46%
|
✗
|
$2.2M |
| Apr 16, 2019 |
Apr 18, 2019 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
67.5
|
+251,835
|
0.37%
|
✗
|
$332.4K |
| Feb 8, 2019 |
Feb 12, 2019 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
92.5
|
+533,333
|
3.41%
|
✗
|
$2M |
| Mar 28, 2018 |
Mar 30, 2018 |
Insight Molecular Diagnostics Inc.
|
10% Owner |
Buy |
100.0
|
+3,968,254
|
35.55%
|
✗
|
$5M |
| Oct 13, 2017 |
Oct 17, 2017 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
93.8
|
+2,692,307
|
4.70%
|
✗
|
$7M |
| Aug 22, 2017 |
Aug 24, 2017 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
48.8
|
+10,000
|
0.02%
|
✗
|
$26K |
| Jul 31, 2017 |
Aug 2, 2017 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
67.5
|
+150,000
|
0.28%
|
✗
|
$420K |
| Feb 15, 2017 |
Feb 17, 2017 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
93.8
|
+2,222,222
|
4.27%
|
✗
|
$6M |
| Jun 28, 2016 |
Jun 30, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
52.5
|
+14,144
|
0.04%
|
✗
|
$74.1K |
| Jun 21, 2016 |
Jun 23, 2016 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
96.3
|
+2,732,636
|
5.81%
|
✗
|
$6.5M |
| May 23, 2016 |
May 25, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
62.5
|
+77,842
|
0.18%
|
✗
|
$401.7K |
| May 17, 2016 |
May 19, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
48.8
|
+9,313
|
0.04%
|
✗
|
$48.7K |
| May 12, 2016 |
May 16, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
77.5
|
+336,210
|
0.79%
|
✗
|
$1.8M |
| Feb 11, 2016 |
Feb 16, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
92.5
|
+554,066
|
2.73%
|
✗
|
$3.3M |
| Feb 11, 2016 |
Feb 16, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
42.5
|
-
|
0.00%
|
✗
|
$3.3M |
| Feb 5, 2016 |
Feb 9, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
67.5
|
+91,770
|
0.23%
|
✗
|
$573.2K |
| Feb 2, 2016 |
Feb 4, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
67.5
|
+121,599
|
0.42%
|
✗
|
$778.8K |
| Jan 28, 2016 |
Feb 1, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
62.5
|
+65,983
|
0.17%
|
✗
|
$427.6K |
| Jan 25, 2016 |
Jan 27, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
77.5
|
+239,013
|
0.63%
|
✗
|
$1.6M |
| Jan 20, 2016 |
Jan 22, 2016 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
75.0
|
+300,000
|
0.68%
|
✗
|
$705K |
| Jan 19, 2016 |
Jan 21, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
67.5
|
+72,858
|
0.26%
|
✗
|
$491.6K |
| Jan 13, 2016 |
Jan 15, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
67.5
|
+135,725
|
0.37%
|
✗
|
$913.2K |
| Jan 8, 2016 |
Jan 12, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
67.5
|
+86,586
|
0.32%
|
✗
|
$591.5K |
| Jan 5, 2016 |
Jan 7, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
77.5
|
+267,047
|
0.75%
|
✗
|
$1.9M |
| Dec 30, 2015 |
Jan 4, 2016 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
70.0
|
+165,461
|
0.48%
|
✗
|
$1.2M |
| Oct 2, 2015 |
Oct 6, 2015 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
93.8
|
+1,600,000
|
3.80%
|
✗
|
$5.1M |
| Sep 25, 2015 |
Sep 29, 2015 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
77.5
|
+311,099
|
0.92%
|
✗
|
$2.2M |
| Sep 14, 2015 |
Sep 16, 2015 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
96.3
|
+2,431,611
|
6.38%
|
✗
|
$8M |
| Aug 21, 2015 |
Aug 25, 2015 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
77.5
|
+188,881
|
0.57%
|
✗
|
$1.4M |
| Nov 17, 2014 |
Nov 19, 2014 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
77.5
|
+189,646
|
0.65%
|
✗
|
$1.6M |
| Nov 10, 2014 |
Nov 12, 2014 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
47.5
|
+500
|
0.00%
|
✗
|
$4.4K |
| Nov 5, 2014 |
Nov 7, 2014 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
67.5
|
+80,000
|
0.28%
|
✗
|
$713.6K |
| Oct 31, 2014 |
Nov 4, 2014 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
77.5
|
+260,341
|
0.93%
|
✗
|
$2.4M |
| Oct 8, 2014 |
Oct 8, 2014 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+4,040,523
|
12.78%
|
✗
|
$12.6M |
| Jul 22, 2014 |
Jul 24, 2014 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
75.0
|
+370,000
|
0.91%
|
✗
|
$980.5K |
| Jun 16, 2014 |
Jun 18, 2014 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
92.5
|
+1,000,000
|
3.87%
|
✗
|
$2.5M |
| May 16, 2014 |
May 16, 2014 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+300,000
|
1.22%
|
✗
|
$735K |
| May 8, 2014 |
May 9, 2014 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+300,000
|
1.25%
|
✗
|
$730.5K |
| May 1, 2014 |
May 5, 2014 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
96.3
|
+2,000,000
|
9.24%
|
✗
|
$5M |
| Feb 25, 2014 |
Feb 27, 2014 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
92.5
|
+500,000
|
2.61%
|
✗
|
$1.9M |
| Dec 26, 2013 |
Dec 30, 2013 |
Lineage Cell Therapeutics, Inc.
|
10% Owner |
Buy |
77.5
|
+300,042
|
0.82%
|
✗
|
$1.1M |
| Dec 12, 2013 |
Dec 16, 2013 |
STAAR SURGICAL CO
|
10% Owner |
Sell |
17.5
|
-214,544
|
-1.53%
|
✗
|
$2.8M |
| Mar 28, 2013 |
Mar 29, 2013 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
85.0
|
+200,000
|
1.15%
|
✗
|
$762K |
| Nov 15, 2012 |
Nov 19, 2012 |
Lineage Cell Therapeutics, Inc.
|
Director |
Buy |
87.5
|
+344,828
|
2.04%
|
✗
|
$1M |
| Nov 15, 2012 |
Nov 19, 2012 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
48.8
|
+2,618
|
0.02%
|
✗
|
$13.1K |
| Nov 2, 2012 |
Nov 6, 2012 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
60.0
|
+22,572
|
0.18%
|
✗
|
$112.9K |
| Jul 31, 2012 |
Aug 2, 2012 |
STAAR SURGICAL CO
|
10% Owner |
Buy |
87.5
|
+296,718
|
1.19%
|
✗
|
$1.5M |